Partial Reconstruction with Thigh Skin Graft for Penile Cancer: Case Presentation, Description of Surgical Technique and Literature Review
Lemme Gustavo Francisco,
Rovegno Federico Agustin,
Capiel Leandro,
Rovegno Agustin Roberto
Issue:
Volume 10, Issue 2, June 2022
Pages:
13-17
Received:
21 December 2021
Accepted:
7 January 2022
Published:
9 April 2022
Abstract: Background: Penile cancer is a rare neoplasm, the most common variety is invasive squamous cell carcinoma or epidermoid carcinoma. Its incidence is very low in developed countries. Partial and radical penectomy has been the gold standard for the treatment of this disease. In recent decades, different reconstructive techniques have been developed with a much lower impact on the quality of life of the patient. Objective: describe a surgical technique to treat premalignant lesions and superficial malignant lesions of the penis, and review of the literature. Method: a description of the surgical technique regarding partial penile reconstruction using a thigh skin graft for the treatment of premalignant lesions and superficial penile cancer was done. The surgery is divided in 6 steps, which includes general preparation, cystoscopy, resection of lesions on the shaft of the penis and scrotum, estimation of graft size and graft taking, preparation and placement of the graft on the shaft of the penis and wound healing, urinary catheter placement and follow-up. Results: this surgery shows a good cosmetic result, without local progression of the underlying disease. Conclusion: Conservative surgical treatment is a possible option in premalignant and malignant penile lesions, as it allows a better quality of life for the patient without affecting overall survival.
Abstract: Background: Penile cancer is a rare neoplasm, the most common variety is invasive squamous cell carcinoma or epidermoid carcinoma. Its incidence is very low in developed countries. Partial and radical penectomy has been the gold standard for the treatment of this disease. In recent decades, different reconstructive techniques have been developed wi...
Show More
Chemotherapy at the End of Life – The Reality of an Oncological Centre
Raquel Fontes,
Jorge Rodrigues,
Camila Oliveira,
Mauricio Peixoto,
Sonia Doria,
Rafael Silva,
Sofia Martins,
Julia Amorim,
Rui Nabiço,
Ana Marques
Issue:
Volume 10, Issue 2, June 2022
Pages:
18-23
Received:
15 April 2022
Accepted:
4 May 2022
Published:
24 May 2022
Abstract: Background: In advanced and incurable cancer disease, chemotherapy may be recommended if it improves the quality of life, even if it does not increase survival. However, in an end-of-life setting, the use of chemotherapy is controversial, with less clear indications and more individualized decisions. This study aimed to evaluate patients who received chemotherapy within the last three months of life, an indicator of the quality of care provided. Methods: We analyzed data from patients receiving chemotherapy in the last 3 months of life and who died from January 2018 to December 2020, in our Oncology Department. Results: It was found that 391 patients received chemotherapy in the last 3 months of life. Most had metastatic disease at diagnosis (71%, n=276) and were treated in a first-line setting. A more detailed analysis revealed that 50% (n=193) underwent treatment in the last month and 22% (n=42) in the last week of life. Most patients died due to disease progression, with 79% of deaths occurring in the hospital. Conclusions: This work puts into figures the reality of an Oncology Centre, revealing the investment made in fighting the disease and providing greater longevity to patients, with quality of life.
Abstract: Background: In advanced and incurable cancer disease, chemotherapy may be recommended if it improves the quality of life, even if it does not increase survival. However, in an end-of-life setting, the use of chemotherapy is controversial, with less clear indications and more individualized decisions. This study aimed to evaluate patients who receiv...
Show More
